Clinical Trial

Personalized Oncogenomics (POG) Program of British Columbia

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 22, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
The genomic heterogeneity of cancers implies that to effectively use targeted therapies the investigators will need to assess each individual cancer and match it to a biologically relevant targeted therapy. The investigators will use full genome sequencing to try to identify cancer "drivers" and corresponding drugs that may inhibit these pathways.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2014-06-03; most recent amendment 2025-09-17.
Status change: Not Yet Recruiting → Recruiting 2015-02-04
Trial Details
NCT Number NCT02155621
Lead Sponsor British Columbia Cancer Agency
Collaborators: BC Cancer Foundation
Conditions Metastatic Cancers, Advanced Cancers, Cancers That Cannot be Treated With Curative Intent
Enrollment 5,000 participants
Start Date 2014-07
Primary Completion 2026-03 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2025-09-22